Do transfusions get to the heart of the matter?
Article Abstract:
A survival analysis using proportional hazards modeling demonstrated that the risk of death was estimated to be 3.94 times higher than in patients who underwent transfusion compared with those who did not, adjusting for the influence of time, risk of bleeding, type of myocardial infraction, and procedure. The study also demonstrates that the red blood transfusion might be beneficial in patients with acute myocardial infraction.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Is leukoreduction of blood components for everyone?
Article Abstract:
There is no clear cut evidence that removing white blood cells from all donated blood will benefit most of the patients who receive a blood transfusion. Removing the white blood cells from all donated blood would cost about $500 million a year. This is usually done to avoid impacting the patient's immune system adversely.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Clinical characteristics and outcome of twin gestation complicated by preterm premature rupture of the membranes
- Abstracts: HMOs liable for actions of their network doctors. Class-action notices require individual consideration. High court punches another hole in federal law shielding HMOs
- Abstracts: Education to achieve symptom control for patients with cancer. The role of mental health education in a primary care setting
- Abstracts: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Clinical outcomes following institution of the Canadian Universal Leukoreduction Program for red blood cell transfusions